ReviewDiabetes & vascular disease research2015
SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.
Silvio E Inzucchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
160 papers cite itlatest 60 shown
this paperpooled ittrialcites it